Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Giorgia BattipagliaMyriam LabopinRose-Marie HamladjiDidier BlaisePatrice ChevallierEolia BrissotArmin GerbitzGerard SociéBoris AfanasyevFabio CiceriEllen MeijerYener KocJan J CornelissenAnne HuynhHakan OzdoguJohan MaertensFranciane PaulHélène Labussière-WalletAnnalisa RuggeriMahmoud AljurfAli BazarbachiBipin P SavaniArnon NaglerMohamad Mohty

Published in: Cancer (2020)

PTCY is feasible in an HLA-identical sibling setting, and despite similar outcomes, ATG may be associated with lower incidence of chronic GVHD.

Keyphrases

stem cell transplantation
high dose
acute myeloid leukemia
allogeneic hematopoietic stem cell transplantation
low dose
cell therapy
risk factors
type diabetes
metabolic syndrome
mesenchymal stem cells
skeletal muscle
bone marrow
glycemic control